Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Weekly Stock Review: Baihua Pharmaceutical (600721) Continues to Suspend Trading as Control Change Plan Remains Under Discussion
As of the close on March 30, 2026, Baihua Pharmaceutical (600721) closed at 10.18 yuan, up 1.8% from 10.0 yuan last week. This week, Baihua Pharmaceutical’s intraday high on March 30 was 10.24 yuan. The intraday low on March 30 was 9.79 yuan. Baihua Pharmaceutical’s current latest total market cap is 3.92B yuan. It ranks 42/51 in the medical services sector by market cap, and 3897/5193 among A-shares across both markets.
Key points this week
Company announcement roundup
Announcement of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd. on the continued suspension of trading related to the planned change of control
Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.’s controlling shareholders and actual controllers, Mr. Mi Zaiqi, Ms. Mi Enhua, and Ms. Yang Xiaoling, are currently planning matters regarding the transfer of the company’s shares under a share agreement. This matter may result in a change in the company’s control. The company’s stock has been suspended from March 31, 2026, and is expected to be suspended for no more than 2 trading days. As the matter is still being planned and there are uncertainties, the company’s stock continues to be suspended from April 2, 2026, and is expected to continue to be suspended for no more than 3 trading days. The company will fulfill its information disclosure obligations in accordance with progress, and once the matter is determined, it will promptly announce it and apply for resumption of trading.
The above content is compiled by Securities Star from publicly available information and generated by an AI algorithm (Network Information Filing No. 310104345710301240019). It does not constitute investment advice.